XLS |
Net sales, operating result (EBIT) and research and development costs, by business sector1 |
||||||||||||||
|
|
|
|
|
|
|
|
|
||||||
€ million |
|
Healthcare |
|
Life Science |
|
Performance Materials |
|
Group |
||||||
|
|
|
|
|
|
|
|
|
||||||
2019 |
|
|
|
|
|
|
|
|
||||||
Net sales |
|
6,714 |
|
6,864 |
|
2,574 |
|
16,152 |
||||||
Operating result (EBIT) |
|
1,149 |
|
1,280 |
|
307 |
|
2,120 |
||||||
R&D costs2 |
|
1,666 |
|
276 |
|
267 |
|
2,268 |
||||||
|
|
|
|
|
|
|
|
|
||||||
2020 |
|
|
|
|
|
|
|
|
||||||
Net sales |
|
6,639 |
|
7,515 |
|
3,380 |
|
17,534 |
||||||
Operating result (EBIT) |
|
1,804 |
|
1,599 |
|
240 |
|
2,985 |
||||||
R&D costs2 |
|
1,640 |
|
313 |
|
274 |
|
2,288 |
||||||
|